News
Screening people in primary care with a wearable heart monitor developed by iRhythm was ... aged 70 or above across the US who wore the Zio XT single-lead electrocardiogram (ECG) device for ...
to have a CV event within 1-year compared to Zio LTCM. Ambulatory cardiac monitors (ACM) enable heart rhythm monitoring for various durations, including Holter monitors (0–48 hours), long-term ...
Demand within our Zio Monitor product line originated from cardiologists ... an impact also recognized by our esteemed partners at the Japanese Heart Rhythm Society. Our entry into the second ...
It plans to submit the Zio Monitor in Q3 and complete compliance ... significant studies at the International Society for Heart and Lung Transplantation conference. The clinical trials are a ...
The next-generation Zio monitor. [Image courtesy of iRhythm] iRhythm ... Investigators presented findings at the Heart Rhythm Society (HRS) 2025 Annual Meeting in San Diego.
Hosted on MSN21d
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is OptimisticPioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis ...
The next-generation Zio monitor. [Image courtesy of iRhythm] A ... HeartBeam develops 3D ECG technology that captures the heart’s electrical signals in 3 non-coplanar directions.
Gabriela “Gabby” Schenone has played softball her entire life. From playing T-ball in a city rec league to becoming a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results